On January 30, 2011, MAPS Clinical Investigators Michael Mithoefer, M.D., and Annie Mithoefer, B.S.N., led a one-day course for the therapists who will conduct the treatment sessions in our upcoming Jordanian …
On January 27, 2011, MAPS Clinical Research Associate Berra Yazar-Klosinski, Ph.D., will meet with Kamila Novak, Program Manager of the contract clinical research organization (CRO) Antaea Medical Services, …
Three Australian clinicians are joining the Israeli therapist training program: Stuart Saker, M.D., a psychiatrist with the Australian armed forces; Fiona MacKenzie, a clinical psychologist (and Stuart’s …
On January 30, 2011, co-therapists Michael Mithoefer, M.D., and Annie Mithoefer, B.S.N., will lead a one-day training course for the therapist team for our Jordanian study of MDMA-assisted psychotherapy …
From January 23-27, 2001, co-therapists Michael Mithoefer, M.D., and Annie Mithoefer, B.S.N., will conduct a therapist training program for the new Israeli clinical team. The meeting will appropriately …
From January 23-27, 2011, MAPS Clinical Investigators Michael Mithoefer, M.D., and Annie Mithoefer, B.S.N., conducted a training course for therapists who will be conducting the treatment sessions in MAPS’ …
On January 10, 2011, our clinical team submitted the documents detailing our new protocol for our new Israeli study of MDMA-assisted psychotherapy for PTSD to the Institutional Review Board (IRB) at Beer …
On January 10, 2011, the final long-term follow-up visit was completed in MAPS’ Swiss study of MDMA-assisted psychotherapy for PTSD. The final subject (out of 12 total) was interviewed 12 months …
Our Swiss MDMA/PTSD study collected video from nearly all of the sessions with treatment subjects. We are now preparing a method to archive the videos for future research purposes. This collection of video …
On October 20, Rick visited with Clinical Investigator Nasser Shuriquie, M.D., at Al-Rashid Hospital to discuss our Jordanian MDMA/PTSD study. The protocol was approved by the Al Rashid Institutional Review …
From Oct. 18- 23, MAPS Executive Director Rick Doblin, Ph.D. will be in Israel and Jordan, where he will meet with Clinical Investigator Moshe Kotler, M.D., of our Israeli study, to discuss starting a …
On Oct. 2, Jordanian Principle Investigator Nasser Shuriquie, M.D., attended a workshop with the Jordanian Food and Drug Administration (JFDA) to enhance his knowledge about clinical research procedures …
